DDX6 is involved in the pathogenesis of inflammatory diseases via NF-κB activation
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.149666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Seiichiro Naito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan; Department …. Hauptthemen laut MEDLINE: NF-kappa B, DEAD-box RNA Helicases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Hokkaido University, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
The IL-6 amplifier was originally discovered as a mechanism for the enhanced activation of NF-κB in non-immune cells. In the IL-6 amplifier, IL-6-STAT3 and NF-κB stimulation is followed by an excessive production of IL-6, chemokines, and growth factors to develop chronic inflammation preceding the development of inflammatory diseases. Previously, using a shRNA-mediated genome-wide screening, we found that DEAD-Box Helicase 6 (DDX6) is a candidate positive regulator of the amplifier. Here, we investigate whether DDX6 is involved in the pathogenesis of inflammatory diseases via the IL-6 amplifier. We found that DDX6-silencing in non-immune cells suppressed the NF-κB pathway and inhibited activation of the IL-6 amplifier, while the forced expression of DDX6 enhanced NF-κB promoter activity independent of the RNA helicase activity of DDX6. The imiquimod-mediated dermatitis model was suppressed by the siRNA-mediated gene downregulation of DDX6. Furthermore, silencing DDX6 significantly reduced the TNF-α-induced phosphorylation of p65/RelA and IκBα, nuclear localization of p65, and the protein levels of IκBα. Mechanistically, DDX6 is strongly associated with p65 and IκBα, but not TRADD, RIP, or TRAF2, suggesting a novel function of DDX6 as an adaptor protein in the NF-κB pathway. Thus, our findings demonstrate a possible role of DDX6 beyond RNA metabolism and suggest DDX6 is a therapeutic target for inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan; Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido Univ…
- Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Molecular Biology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan; Group of Quantum Immunology, Institute for Quantum Life Science, National Institu…
- Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Electronic address: hashimot@igm.hokudai.ac.jp.
Förderung
- Japan Agency for Medical Research and Development
- Hokkaido University
- Ministry of Education, Culture, Sports, Science and Technology
- JST
Zitieren
APA
Naito, S., Tanaka, H., Jiang, J. J., Tarumi, M., Hashimoto, A., Tanaka, Y., Murakami, K., Kubota, S. I., Hojyo, S., Hashimoto, S., & Murakami, M. (2024). DDX6 is involved in the pathogenesis of inflammatory diseases via NF-κB activation. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.149666
Vancouver
Naito S, Tanaka H, Jiang JJ, Tarumi M, Hashimoto A, Tanaka Y, et al. DDX6 is involved in the pathogenesis of inflammatory diseases via NF-κB activation. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.149666
BibTeX
@article{Naito2024,
author = {Naito, Seiichiro and Tanaka, Hiroki and Jiang, Jing-Jing and Tarumi, Masato and Hashimoto, Ari and Tanaka, Yuki and Murakami, Kaoru and Kubota, Shimpei I and Hojyo, Shintaro and Hashimoto, Shigeru and Murakami, Masaaki},
title = {DDX6 is involved in the pathogenesis of inflammatory diseases via NF-κB activation},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.149666}
}
EUVIMED